{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:10:54Z","timestamp":1788844254305,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:00:00Z","timestamp":1752796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.ejphar.2025.177973","type":"journal-article","created":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T23:10:52Z","timestamp":1752880252000},"page":"177973","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Pharmacological characterization of a new synthesis compound with antagonistic action on CB1 receptors: Evidence from the animal experimental model"],"prefix":"10.1016","volume":"1003","author":[{"given":"Fabiana","family":"Plescia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4962-379X","authenticated-orcid":false,"given":"Gianluca","family":"Lavanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1996-6529","authenticated-orcid":false,"given":"Maria Grazia","family":"Zizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6124-3471","authenticated-orcid":false,"given":"Cesare","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Bellocchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginevra","family":"Malta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Vaccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Cannizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leila","family":"Dimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4786-8435","authenticated-orcid":false,"given":"Fulvio","family":"Plescia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejphar.2025.177973_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3390\/molecules30030555","article-title":"Exploring quinazoline as a scaffold for developing novel therapeutics in Alzheimer's disease","volume":"30","author":"Abualassal","year":"2025","journal-title":"Molecules"},{"key":"10.1016\/j.ejphar.2025.177973_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.brainresbull.2021.06.022","article-title":"The role of endocannabinoid pathway in the neuropathology of Alzheimer's disease: can the inhibitors of MAGL and FAAH prove to be potential therapeutic targets against the cognitive impairment associated with Alzheimer's disease?","volume":"174","author":"Bajaj","year":"2021","journal-title":"Brain Res. Bull."},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2025.177973_bib3","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2007.12.016","article-title":"Cannabinoid CB1 receptor activation modulates spontaneous contractile activity in mouse ileal longitudinal muscle","volume":"582","author":"Baldassano","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177973_bib4","doi-asserted-by":"crossref","first-page":"5734","DOI":"10.3390\/ijms23105734","article-title":"Exploration of multiverse activities of endocannabinoids in biological systems","volume":"23","author":"Behl","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177973_bib5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1212\/01.wnl.0000267407.79757.75","article-title":"Endocannabinoids in basal ganglia circuits","volume":"69","author":"Benarroch","year":"2007","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177973_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.neuropharm.2010.07.005","article-title":"Revisiting the complex influences of cannabinoids on motor functions unravels pharmacodynamic differences between cannabinoid agonists","volume":"59","author":"Bosier","year":"2010","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.ejphar.2025.177973_bib7","doi-asserted-by":"crossref","DOI":"10.1177\/0269881117725683","article-title":"Reward-related limbic memory and stimulation of the cannabinoid system: an upgrade in value attribution?","volume":"32","author":"Brancato","year":"2018","journal-title":"J. Psychopharmacol."},{"issue":"11","key":"10.1016\/j.ejphar.2025.177973_bib8","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1523\/JNEUROSCI.5404-03.2004","article-title":"Expression of cannabinoid CB1 receptors by vagal afferent neurons is inhibited by Cholecystokinin","volume":"24","author":"Burdyga","year":"2004","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177973_bib9","doi-asserted-by":"crossref","first-page":"652","DOI":"10.3390\/life12050652","article-title":"Effects of cannabidiol on locomotor activity","volume":"12","author":"Calapai","year":"2022","journal-title":"Life"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177973_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuron.2012.09.020","article-title":"Endocannabinoid signaling and synaptic function","volume":"76","author":"Castillo","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.ejphar.2025.177973_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2024.115175","article-title":"Acute rimonabant treatment prevents anhedonia and memory loss in rats submitted to mild restraint stress","volume":"474","author":"Chagas","year":"2024","journal-title":"Behav. Brain Res."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177973_bib12","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0022-3565(25)10448-5","article-title":"Aminoalkylindole analogs: cannabimimetic activity of a class of compounds structurally distinct from delta 9-tetrahydrocannabinol","volume":"263","author":"Compton","year":"1992","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177973_bib13","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1503\/cmaj.110837","article-title":"Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial","volume":"184","author":"Corey-Bloom","year":"2012","journal-title":"Can. Med. Assoc. J."},{"issue":"4","key":"10.1016\/j.ejphar.2025.177973_bib14","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.nlm.2010.01.010","article-title":"SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and social recognition tasks in rodents","volume":"93","author":"de Bruin","year":"2010","journal-title":"Neurobiol. Learn. Mem."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177973_bib15","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pain.2003.12.003","article-title":"A quantitative somatosensory testing of pain threshold in individuals with mental retardation","volume":"108","author":"Defrin","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2025.177973_bib16","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neuroscience.2013.12.030","article-title":"Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia","volume":"261","author":"Desroches","year":"2014","journal-title":"Neuroscience"},{"issue":"6","key":"10.1016\/j.ejphar.2025.177973_bib17","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.ejphar.2025.177973_bib18","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/gut.2005.090472","article-title":"Endocannabinoid overactivity and intestinal inflammation","volume":"55","author":"Di Marzo","year":"2006","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.ejphar.2025.177973_bib19","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","article-title":"The endocannabinoid system and its modulation by phytocannabinoids","volume":"12","author":"Di Marzo","year":"2015","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177973_bib20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1586\/17474124.2.3.385","article-title":"Role of cannabinoid receptors in the control of gastrointestinal motility and perception","volume":"2","author":"Fioramonti","year":"2008","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177973_bib21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 Cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"J. Neurophysiol."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177973_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"issue":"51","key":"10.1016\/j.ejphar.2025.177973_bib23","doi-asserted-by":"crossref","first-page":"18620","DOI":"10.1073\/pnas.0509591102","article-title":"Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis","volume":"102","author":"Gobbi","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejphar.2025.177973_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113949","article-title":"Therapeutic potential of quinazoline derivatives for Alzheimer's disease: a comprehensive review","volume":"227","author":"Haghighijoo","year":"2022","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177973_bib25","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0893-133X(01)00273-1","article-title":"Effects of Acute smoked Marijuana on complex cognitive performance","volume":"25","author":"Hart","year":"2001","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177973_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2045-5380-3-19","article-title":"Translational evidence for the involvement of the endocannabinoid system in stress-related psychiatric illnesses","volume":"3","author":"Hill","year":"2013","journal-title":"Biol. Mood Anxiety Disord."},{"issue":"7664","key":"10.1016\/j.ejphar.2025.177973_bib27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/nature23272","article-title":"Crystal structures of agonist-bound human cannabinoid receptor CB1","volume":"547","author":"Hua","year":"2017","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejphar.2025.177973_bib28","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.cell.2016.10.004","article-title":"Crystal structure of the human cannabinoid receptor CB1","volume":"167","author":"Hua","year":"2016","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.ejphar.2025.177973_bib29","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1021\/jm980363y","article-title":"Structure\u2212Activity relationships of pyrazole derivatives as cannabinoid receptor antagonists","volume":"42","author":"Lan","year":"1999","journal-title":"J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177973_bib30","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S1359-6446(05)03427-6","article-title":"Keynote review: medicinal chemistry strategies to CB1 cannabinoid receptor antagonists","volume":"10","author":"Lange","year":"2005","journal-title":"Drug Discov. Today"},{"issue":"9","key":"10.1016\/j.ejphar.2025.177973_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/1440-1681.12967","article-title":"The endocannabinoid-alcohol crosstalk: recent advances on a bi-faceted target","volume":"45","author":"Lavanco","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177973_bib33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1124\/jpet.104.077974","article-title":"Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence","volume":"312","author":"Le Foll","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2025.177973_bib34","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ejmech.2012.12.056","article-title":"Novel pyrazole derivatives as neutral CB 1 antagonists with significant activity towards food intake","volume":"62","author":"Manca","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejphar.2025.177973_bib35","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1016\/j.cub.2023.09.075","article-title":"Striatopallidal cannabinoid type-1 receptors mediate amphetamine-induced sensitization","volume":"33","author":"Mariani","year":"2023","journal-title":"Curr. Biol."},{"key":"10.1016\/j.ejphar.2025.177973_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pnpbp.2014.11.010","article-title":"Effects of rimonabant on the development of single dose-induced behavioral sensitization to ethanol, morphine and cocaine in mice","volume":"58","author":"Marinho","year":"2015","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177973_bib37","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0091-3057(91)90349-7","article-title":"Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs","volume":"40","author":"Martin","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3 Suppl. l","key":"10.1016\/j.ejphar.2025.177973_bib38","first-page":"47","article-title":"Endocannabinoids and the gastrointestinal tract","volume":"29","author":"Massa","year":"2006","journal-title":"J. Endocrinol. Investig."},{"issue":"S1","key":"10.1016\/j.ejphar.2025.177973_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/j.1552-4604.2002.tb05998.x","article-title":"Cannabidiol: an overview of some pharmacological aspects","volume":"42","author":"Mechoulam","year":"2002","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2025.177973_bib40","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/15504263.2019.1668100","article-title":"Cannabinoid receptor type 1 and its role as an analgesic: an opioid alternative?","volume":"16","author":"Milligan","year":"2020","journal-title":"J. Dual Diagn."},{"issue":"2","key":"10.1016\/j.ejphar.2025.177973_bib41","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0163-7258(97)82001-3","article-title":"Pharmacology of cannabinoid CB1 and CB2 receptors","volume":"74","author":"Pertwee","year":"1997","journal-title":"Pharmacol. Therapeut."},{"issue":"S1","key":"10.1016\/j.ejphar.2025.177973_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjp.0706406","article-title":"Cannabinoid pharmacology: the first 66 years","volume":"147","author":"Pertwee","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.ejphar.2025.177973_bib43","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/j.1476-5381.1996.tb15663.x","article-title":"Further evidence for the presence of cannabinoid CB 1 receptors in guinea\u2010pig small intestine","volume":"118","author":"Pertwee","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177973_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2013.00064","article-title":"Acetaldehyde as a drug of abuse: insight into AM281 administration on operant-conflict paradigm in rats","author":"Plescia","year":"2013","journal-title":"Front. Behav. Neurosci."},{"issue":"6","key":"10.1016\/j.ejphar.2025.177973_bib45","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.pharep.2018.06.004","article-title":"The role of (E)-6-chloro-3-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-2-styrylquinazolin-4(3H)-one in the modulation of cannabinoidergic system. A pilot study","volume":"70","author":"Plescia","year":"2018","journal-title":"Pharmacol. Rep."},{"issue":"21","key":"10.1016\/j.ejphar.2025.177973_bib46","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.1111\/bph.13973","article-title":"Antidote to cannabinoid intoxication: the CB 1 receptor inverse agonist, AM251, reverses hypothermic effects of the CB 1 receptor agonist, CB\u201013, in mice","volume":"174","author":"Pryce","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177973_bib47","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1124\/jpet.301.3.963","article-title":"CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4,5-Dihydro-2-methyl-4(4-morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6 H-pyrrolo[3,2,1ij]quinolin-6-one]-Induced hypothermia","volume":"301","author":"Rawls","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"issue":"10","key":"10.1016\/j.ejphar.2025.177973_bib48","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s11892-017-0924-x","article-title":"Re-visiting the endocannabinoid system and its therapeutic potential in obesity and associated diseases","volume":"17","author":"Richey","year":"2017","journal-title":"Curr. Diabetes Rep."},{"key":"10.1016\/j.ejphar.2025.177973_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2020.135021","article-title":"Functional role for preoptic CB1 receptors in breathing and thermal control","volume":"732","author":"Ripamonte","year":"2020","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2025.177973_bib50","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.yebeh.2016.09.040","article-title":"Cannabis and epilepsy: an ancient treatment returns to the fore","volume":"70","author":"Russo","year":"2017","journal-title":"Epilepsy Behav."},{"issue":"5","key":"10.1016\/j.ejphar.2025.177973_bib51","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.bjp.0707422","article-title":"Endocannabinoids and the gastrointestinal tract: what are the key questions?","volume":"152","author":"Sanger","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.ejphar.2025.177973_bib52","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1038\/npp.2016.27","article-title":"Blockade of nicotine and cannabinoid reinforcement and relapse by a cannabinoid CB1-Rreceptor neutral antagonist AM4113 and inverse agonist rimonabant in squirrel monkeys","volume":"41","author":"Schindler","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.ejphar.2025.177973_bib54","doi-asserted-by":"crossref","first-page":"G110","DOI":"10.1152\/ajpgi.00148.2003","article-title":"Cannabinoid receptor type 1 modulates excitatory and inhibitory neurotransmission in mouse colon","volume":"286","author":"Storr","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"10125","key":"10.1016\/j.ejphar.2025.177973_bib55","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet"},{"issue":"1\u20133","key":"10.1016\/j.ejphar.2025.177973_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2003.08.101","article-title":"The endocannabinoid system in the basal ganglia and in the mesolimbic reward system: implications for neurological and psychiatric disorders","volume":"480","author":"van der Stelt","year":"2003","journal-title":"Eur. J. Pharmacol."},{"issue":"21","key":"10.1016\/j.ejphar.2025.177973_bib57","doi-asserted-by":"crossref","first-page":"12198","DOI":"10.1073\/pnas.96.21.12198","article-title":"Pain modulation by release of the endogenous cannabinoid anandamide","volume":"96","author":"Walker","year":"1999","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"3","key":"10.1016\/j.ejphar.2025.177973_bib58","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2003.08.025","article-title":"SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task","volume":"477","author":"Wolff","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2025.177973_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2011.00057","article-title":"Effects of endocannabinoid system modulation on cognitive and emotional behavior","volume":"5","author":"Zanettini","year":"2011","journal-title":"Front. Behav. Neurosci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925007277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925007277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:28:33Z","timestamp":1754008113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925007277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":57,"alternative-id":["S0014299925007277"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177973","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological characterization of a new synthesis compound with antagonistic action on CB1 receptors: Evidence from the animal experimental model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.177973","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"177973"}}